Pharmacodynamic comparison of acarbose tablets in Chinese healthy volunteers under chewing and swallowing conditions

阿卡波糖 最大值 医学 交叉研究 剂量 药代动力学 药效学 剂型 药理学 丸(消化) 麻醉 安慰剂 内科学 内分泌学 糖尿病 替代医学 病理
作者
Wei Ji,Shaomei Yang,Wenyu Zhang,Zhongliang Sun,Qing Wen,Kun He
出处
期刊:Journal of Clinical Pharmacy and Therapeutics [Wiley]
卷期号:46 (3): 814-819
标识
DOI:10.1111/jcpt.13361
摘要

What is known and objective Acarbose can efficiently block glucose absorption in the intestine as an alpha-glucosidase inhibitor. It is currently manufactured in several oral dosage forms, with the most common types being tablets and chewable tablets. The acarbose tablet (Glucobay®, 50 mg, Bayer) package insert gives instructions for either directly swallowing or chewing then swallowing. This study compared the pharmacodynamic effects of a single formulation of acarbose tablets under these two different administration routes. Methods This randomized, crossover study enrolled 24 healthy subjects who were instructed to chew (C group) or swallow (S group) the acarbose tablet. Glucose levels were monitored in subjects for up to 4 h following administration of 75 g of sucrose to establish a baseline firstly, after which subjects in the C and S groups were administered 50- or 100- mg of acarbose along with 75 g of sucrose. Then, subjects entered a 1-week washout period before being crossed over to the alternate dosing route. Results and discussion Compared with the S group, the C group had a lower maximum concentration of serum glucose (Cmax) and areas under the concentration–time curve (AUC0-2, AUC0-1.5). In addition, the maximum reduction in serum glucose (ΔCmax) and the reduction in the AUC (AUEC0-1.5) were both increased in the S group. This occurred at both the 50 mg and 100 mg dosages. These results indicate that fluctuations in blood glucose were lower following chewing of the acarbose tablet. Both administration routes exhibited similar safety and tolerance profiles. What is new and conclusion In summary, chewing acarbose tablets appears to induce a superior glycaemic-controlling effect compared with swallowing them directly, at least with a single dose. It will be important to inform both clinicians and patients about these differences between the two administrations so that informed clinical decisions can be made, as numerous patients with diabetes are inclined to directly swallow acarbose tablets for convenience.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
飞哥与小佛完成签到,获得积分10
3秒前
乐乐的应助被王勾勾采纳,获得10
3秒前
macrossfev完成签到,获得积分10
3秒前
活泼雪莲发布了新的文献求助10
8秒前
save完成签到,获得积分10
9秒前
柠檬普洱茶完成签到,获得积分10
15秒前
安静怜雪完成签到,获得积分10
17秒前
Cosmosurfer完成签到,获得积分0
19秒前
观澜完成签到 ,获得积分10
19秒前
mousfy完成签到 ,获得积分10
22秒前
科研界的小白完成签到 ,获得积分10
22秒前
在水一方的应助被369ninja采纳,获得10
24秒前
任某人完成签到 ,获得积分10
25秒前
peterlaa3完成签到,获得积分10
25秒前
恬恬完成签到 ,获得积分10
26秒前
hamburger完成签到 ,获得积分10
26秒前
seawolf168完成签到,获得积分10
27秒前
种子完成签到,获得积分10
29秒前
meow完成签到 ,获得积分10
29秒前
sci完成签到 ,获得积分10
30秒前
jeronimo完成签到,获得积分10
32秒前
Az完成签到 ,获得积分10
33秒前
健忘语梦完成签到 ,获得积分10
35秒前
冯小晴完成签到 ,获得积分10
36秒前
chilit完成签到 ,获得积分10
37秒前
fxy完成签到 ,获得积分10
38秒前
泥猴桃完成签到,获得积分10
43秒前
白昼完成签到 ,获得积分10
43秒前
43秒前
小马甲的应助被活泼雪莲采纳,获得10
45秒前
如意大神完成签到,获得积分10
45秒前
麻衣少年完成签到 ,获得积分10
46秒前
Robin完成签到 ,获得积分10
46秒前
任俊涛完成签到,获得积分10
46秒前
南风完成签到,获得积分10
46秒前
xuyeqiao完成签到 ,获得积分10
48秒前
cherry_mm发布了新的文献求助30
49秒前
LWJ要毕业完成签到 ,获得积分10
51秒前
雪山大地发布了新的文献求助10
52秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166550
求助须知:如何正确求助?哪些是违规求助? 9559535
关于积分的说明 21750720
捐赠科研通 7757357
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553523
邀请新用户注册赠送积分活动 2473904